Prevalence and association testing of antinuclear antibodies and inflammatory bowel disease in Taiwan
PeerJ · 2025
DOI: 10.7717/peerj.20474 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von Tsai-Min Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Changhua Christian Hospital, Changhua, Taiwan. Hauptthemen laut MEDLINE: Antibodies, Antinuclear, Crohn Disease, Inflammatory Bowel Diseases, Colitis, Ulcerative. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changhua Christian Hospital.
Abstract (Originalsprache)
Background
Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are characterized by chronic inflammation of the gastrointestinal tract. Antinuclear antibodies (ANAs), which are autoantibodies directed against nuclear components, are commonly present in various autoimmune disorders. We investigated the prevalence and clinical significance of ANAs in Taiwanese patients with IBD.
Methods
From January 2017 to December 2024, ANA status was checked at initial diagnosis of IBD in patients from a medical center in central Taiwan. Risk factors for ANA positivity were evaluated.
Results
Of the 166 patients in this study, 57 had CD and 109 had UC. ANA test results were positive (titers of ≥ 1:160) in 26 patients (15.7%). Older age at disease diagnosis ( p < 0.05) and a diagnosis of UC ( p < 0.05) were statistically significant risk factors for ANA positivity. Gender ( p = 0.31), use of advanced therapy ( p = 0.66), and the presence of extraintestinal manifestations (EIMs) ( p = 0.14) were not associated with ANA positivity. The response to anti-tumor necrosis factor therapy did not differ between ANA-positive and ANA-negative patients ( p = 0.34). The most frequent ANA staining patterns were AC1, AC3, and AC4.
Conclusions
These findings suggest that although ANA positivity is relatively common among Taiwanese patients with IBD, particularly among older UC patients. Further validation is required to explore the clinical implications of ANA positivity in Asian population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Changhua Christian Hospital, Changhua, Taiwan.
- Frontier Molecular Medical Research Center in Children, Changhua Christian Children Hospital, Changhua, Taiwan.
- Department of Pediatrics, Changhua Christian Children Hospital, Changhua, Taiwan.
- Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taichung, Taiwan.
ORCID-Profile: Hsu-Heng Yen, Yang-Yuan Chen
Förderung
- Changhua Christian Hospital
Zitieren
APA
Yang, T. M., Lu, F. T., Yen, H. H., & Chen, Y. Y. (2025). Prevalence and association testing of antinuclear antibodies and inflammatory bowel disease in Taiwan. PeerJ. https://doi.org/10.7717/peerj.20474
Vancouver
Yang TM, Lu FT, Yen HH, Chen YY. Prevalence and association testing of antinuclear antibodies and inflammatory bowel disease in Taiwan. PeerJ. 2025. doi:10.7717/peerj.20474
BibTeX
@article{Yang2025,
author = {Yang, Tsai-Min and Lu, Fang-Ting and Yen, Hsu-Heng and Chen, Yang-Yuan},
title = {Prevalence and association testing of antinuclear antibodies and inflammatory bowel disease in Taiwan},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.20474}
}
EUVIMED